ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ESPR Esperion Therapeutics Inc

2.98
0.07 (2.41%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Esperion Therapeutics Inc NASDAQ:ESPR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.07 2.41% 2.98 2.42 3.18 2.995 2.77 2.88 7,959,420 05:00:10

Esperion to Participate in Upcoming May Investor Conferences

29/04/2024 1:00pm

GlobeNewswire Inc.


Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart


From Apr 2024 to Jun 2024

Click Here for more Esperion Therapeutics Charts.

Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of May, which can be found on our investor relations website.

JMP Securities’ Life Sciences Conference in New York on May 13, 2024, at 2:30 p.m. ET.

Bank of America Securities’ 2024 Health Care Conference in Las Vegas on May 15, 2024, at 3:00 p.m. PT / 6:00 p.m. ET.

H.C. Wainwright’s 2nd Annual BioConnect Investor Conference in New York on May 20, 2024, at 10:00 a.m. ET.

Live webcasts can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for approximately 90 days.

Esperion TherapeuticsAt Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases. The status quo is not meeting the health needs of millions of people with high cholesterol – that is why our team of passionate industry leaders is breaking through the barriers that prevent patients from reaching their goals. Providers are moving toward reducing LDL-cholesterol levels as low as possible, as soon as possible; we provide the next steps to help get patients there. Because when it comes to high cholesterol, getting to goal is not optional. It is our life’s work. For more information, visit esperion.com and esperionscience.com and follow us on X at twitter.com/EsperionInc.

Esperion Contact Information:Investors: investorrelations@esperion.com

Media: Tiffany Aldrich corporateteam@esperion.com (616) 443-8438

1 Year Esperion Therapeutics Chart

1 Year Esperion Therapeutics Chart

1 Month Esperion Therapeutics Chart

1 Month Esperion Therapeutics Chart

Your Recent History

Delayed Upgrade Clock